| __timestamp | Novavax, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 4101058 |
| Thursday, January 1, 2015 | 162644000 | 10763215 |
| Friday, January 1, 2016 | 237939000 | 5579049 |
| Sunday, January 1, 2017 | 168435000 | 32051299 |
| Monday, January 1, 2018 | 173797000 | 24482286 |
| Tuesday, January 1, 2019 | 113842000 | 43892589 |
| Wednesday, January 1, 2020 | 747027000 | 44505000 |
| Friday, January 1, 2021 | 2534508000 | 79406000 |
| Saturday, January 1, 2022 | 1235278000 | 49283000 |
| Sunday, January 1, 2023 | 737502000 | 17282730 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Novavax, Inc. and Verona Pharma plc have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Novavax's R&D expenses surged by over 900%, peaking in 2021 with a staggering $2.5 billion, driven by their COVID-19 vaccine efforts. In contrast, Verona Pharma's R&D spending, while more modest, increased by approximately 300%, reaching its highest in 2021 with nearly $80 million. This disparity highlights Novavax's aggressive investment strategy compared to Verona Pharma's more measured approach. As the biotech landscape evolves, these spending patterns may influence each company's future breakthroughs and market positioning.
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
R&D Spending Showdown: Zoetis Inc. vs Novavax, Inc.
Biogen Inc. or Novavax, Inc.: Who Invests More in Innovation?
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
R&D Insights: How Opthea Limited and Novavax, Inc. Allocate Funds
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Novavax, Inc.